Adding subcutaneous insulin degludec early to IV insulin may accelerate diabetic ketoacidosis resolution and improve glycemic outcomes without added risk.
A global analysis reveals growing diabetes burden linked to alcohol consumption, with projections pointing to continued increases without targeted intervention. This study was presented at the Endocrine...
Anuradha Krishnan, BA, research analyst at dQ&A, previews her presentation at the 2025 American Diabetes Association Scientific Sessions, sharing findings from a multi-country survey examining how...
Continuous glucose monitoring adherence significantly lowers emergency and inpatient visits for diabetes-related complications in people with type 2 diabetes on intensive insulin therapy. The authors...
A retrospective cohort study presented at the American Diabetes Association found that combining continuous glucose monitoring (CGM) with GLP-1 agonist therapy led to significantly greater reductions in...
A real-world study of a fasting mimicking diet program showed improved glycemic control, medication reduction, and weight loss in people with type 2 diabetes, with high engagement and satisfaction rates....
For patients with type 2 diabetes and established cardiovascular or kidney disease, daily oral semaglutide significantly lowered the risk of major adverse cardiovascular events during a median of 49.5...
Explore how value-based care providers can navigate the clinical and financial impact of emerging therapies, biosimilars, and federal drug pricing reforms.
According to a study presented at the American Association of Clinical Endocrinology Annual Meeting 2025, patients with type 2 diabetes face significantly lower bone mineral density and an increased risk of...
At the Practical Updates in Primary Care 2025 conference, Julianne Blythe, MPA, PA-C, RPSGT, outlined practical strategies for identifying and managing obstructive sleep apnea, emphasizing screening tools,...
